About the company
AbbVie is a research-driven biopharmaceutical company headquartered in North Chicago, Illinois, focused on immunology, oncology, neuroscience, eye care and aesthetics after its 2013 spin-off from Abbott.
Sector
Pharmaceutical
Facilities
—
Markets served
—
Company milestones
No milestones listed yet — companies can add their history once they claim this page.
Leadership team
Corporate Executive Office
Global Leadership
Senior leadership directing R&D, commercial strategy, and biomanufacturing operations.
Products, services & capabilities
Core Capability
Biopharmaceutical R&D & Manufacturing
Advanced therapeutic development, sterile formulation, and quality assurance.
Certifications & awards
No certifications or awards listed yet — companies can add these once they claim this page.
Partners & clients
No partners or clients listed yet — companies can add these once they claim this page.
Facilities & lab gallery
Articles by AbbVieAll coverage →
Editorially reviewed coverage mentioning this company.
Global Biopharma M&A Rebounds in 2026: AbbVie and Merck KGaA Lead Multi-Billion Dollar Acquisitions
Global pharmaceutical dealmaking has surged in 2026 as cash-rich majors AbbVie and Merck KGaA close multi-bil…
AbbVie Nears $11 Billion Acquisition of Apogee Therapeutics to Bolster Immunology Pipeline
AbbVie is reportedly in advanced negotiations to acquire clinical-stage biotech Apogee Therapeutics for appro…
Is this your company?
Register to manage your profile, publish articles to our readers, list your product catalogue and post jobs — all from one dashboard.